John Sweetenham

11.0k citations
143 papers · 4.7k · 2 hit papers · h-index 35

Impact in

Papers in

John Sweetenham

140 papers receiving 4.6k citations

John Sweetenham's Hit Papers

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial 2015 · 482 citations
4820+5+11Years since publication100200300400500

Peers

John Sweetenham
Comparison fields: 5 of 111
  • Pathology and Forensic Medicine 2.6k
  • Genetics 1.3k
  • Oncology 1.7k
  • Hematology 700
  • Neurology 612
Replace Simon Rule with:
Simon Rule United Kingdom
Mathias Rummel Germany
Sonali M. Smith United States
Michael Unterhalt Germany
N. Niederle Germany
Paolo G. Gobbi Italy
Jorge Romaguera United States
Petr Starostik United States
F. Cavalli Switzerland
Paul A. Hamlin United States
John Sweetenham relative to Simon Rule United Kingdom Simon Rule's profile →
Citations per field
00.5×1.5×2.1×
Simon Rule · 1×
Citations per year

Countries citing papers authored by John Sweetenham

Since Specialization
Citations

This map shows the geographic impact of John Sweetenham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Sweetenham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Sweetenham more than expected).

Fields of papers citing papers by John Sweetenham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Sweetenham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Sweetenham. The network helps show where John Sweetenham may publish in the future.

Co-authors

The 25 scholars most cited alongside John Sweetenham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Sweetenham Line = papers co-authored together John Sweetenham links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Hit paper breakdown →
2009590
2
Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2015482
3 2000240
4 2018162
5 2009124
6 1999117
7 1997116
8 1998114
9 2003108
10 2005106
11 200699
12 200093
13 200987
14 201582
15 199679
16 200977
17 200171
18 200762
19 201359
20 199452

About John Sweetenham

John Sweetenham is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Hematology and Neurology, having authored 143 papers that have together received 4.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (84 papers), Chronic Lymphocytic Leukemia Research (27 papers), Viral-associated cancers and disorders (21 papers), CNS Lymphoma Diagnosis and Treatment (18 papers), Hematopoietic Stem Cell Transplantation (17 papers), CAR-T cell therapy research (13 papers), Acute Lymphoblastic Leukemia research (11 papers) and Neutropenia and Cancer Infections (10 papers). The work is most often cited by research in Pathology and Forensic Medicine (2.6k citations), Genetics (1.3k citations), Oncology (1.7k citations), Hematology (700 citations) and Neurology (612 citations). John Sweetenham has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Graham M. Mead, Lisa Rybicki, Brad Pohlman, Ronald Sobecks, Julie M. Vose, Robert M. Dean, Dennis H. Wright, Brian J. Bolwell, Anthony H. Goldstone and John P. Leonard. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Bone Marrow Transplantation and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact